drugset / Trial / NCT03489239
Entecavir to TAF Switch
NaSingle-groupOpen-labelOther
Summary
A research study to observe the safety, efficacy and tolerability of switching from Entecavir (ETV) to Tenofovir Alafenamide TAF in patients with chronic hepatitis B
Timeline
- Start
- 2017-11-16
- Primary completion
- 2020-08-15
- Completion
- 2020-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tenofovir alafenamide | Small molecule | 25 mg | — |